Huaren Pharmaceutical (300110.SZ): Currently, the product field has not yet involved traditional Chinese medicine business.

On November 28, Gelonghui reported that huaren pharmaceutical (300110.SZ) stated on the investor interaction platform that the company mainly engages in the research and development, production, and sales of peritoneal hemodialysis solutions, respiratory medications, large-volume parenteral solutions (including non-pvc soft bags, upright soft bags, plastic bottles, and glass bottles for large-volume parenteral solutions), controlled substances, active pharmaceutical ingredients, supporting pharmaceutical packaging materials, and medical instruments. The current product field has not yet involved traditional chinese medicine business.

Gelonghui FinanceNov 28 15:24

Huaren pharmaceutical (300110.SZ): The wholly-owned subsidiary has obtained the medical instruments registration certificate for disposable tracheal intubation.

On November 27, Gelonghui reported that huaren pharmaceutical (300110.SZ) announced that its wholly-owned subsidiary, Qingdao Huaren Medical Supplies Co., Ltd., has received the "Medical Instruments Registration Certificate" for "Disposable Tracheal Intubation" issued by the Shandong Provincial Drug Administration. The product models include HRQC-11, HRQC-12, HRQC-13, HRQC-14, HRQC-21, HRQC-22, HRQC-23, HRQC-24; the product includes 138 model specifications, used to establish artificial airways for clinical anesthesia or emergency treatment.

Gelonghui FinanceNov 27 17:38

Huaren Pharmaceutical (300110.SZ): The monkeypox virus testing kit has not yet obtained domestic registration certificate, and no orders have been generated yet.

Gelonghui reported on November 18th that huaren pharmaceutical (300110.SZ) stated on the investor interaction platform that the monkeypox virus testing kit has not yet obtained domestic registration certificate and has not generated any orders.

Gelonghui FinanceNov 18 15:58

Express News | November 8th listed companies' shareholding summary: guangdong huate gas co., ltd and other 10 stocks plan to reduce their holdings (table)

BreakingsNov 8 22:14

huaren pharmaceutical (300110.SZ): Red Tower Innovation completes the shareholding of 1.00% of the shares

George Hong November 8th | Huaren Pharmaceutical (300110.SZ) announced that it has recently received a notification from Red Tower Innovation regarding the implementation of the shareholding reduction plan for Huaren Pharmaceutical. The above-mentioned shareholding reduction plan by Red Tower Innovation has been completed. Red Tower Innovation has cumulatively reduced its shareholding by 11,800,000 shares during this shareholding reduction plan period, with a shareholding reduction percentage of 1.00%.

Gelonghui FinanceNov 8 20:41

Express News | Huaren Pharmaceutical: The company has obtained the pharmaceutical registration certificate for sodium etidronate injection.

BreakingsNov 5 16:26